HPS vs NMAI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HPS presents as a stable but stagnant income vehicle, characterized by a Piotroski F-Score of 6/9 indicating stable financial health. While the Graham Number of $19.45 suggests a defensive undervaluation, this is countered by a low growth-based intrinsic value of $8.19 and a bearish technical trend. The primary concern is a dividend payout ratio of 112.82%, which indicates the current 9.07% yield is unsustainable and being funded by capital rather than earnings. Overall, the fund is a classic yield trap with strong margins but declining earnings growth.
NMAI presents a stark contradiction between its deterministic health markers and its value profile. The Piotroski F-Score of 1/9 indicates severe fundamental weakness by corporate standards, which heavily weighs down the health assessment. However, the fund is trading at a significant discount to its intrinsic value of $17.01 and offers a robust 10.03% dividend yield with a sustainable payout ratio. While long-term price performance is strong, the current technical trend is sharply bearish (10/100), suggesting a period of consolidation or decline despite the valuation gap.
Compare Another Pair
Related Comparisons
HPS vs NMAI: Head-to-Head Comparison
This page compares John Hancock Preferred Income Fund III (HPS) and Nuveen Multi-Asset Income Fund (NMAI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.